[go: up one dir, main page]

PE20030492A1 - Baja concentracion de peroxido para el tratamiento o prevencion de enfermedades vaginales - Google Patents

Baja concentracion de peroxido para el tratamiento o prevencion de enfermedades vaginales

Info

Publication number
PE20030492A1
PE20030492A1 PE2002001057A PE2002001057A PE20030492A1 PE 20030492 A1 PE20030492 A1 PE 20030492A1 PE 2002001057 A PE2002001057 A PE 2002001057A PE 2002001057 A PE2002001057 A PE 2002001057A PE 20030492 A1 PE20030492 A1 PE 20030492A1
Authority
PE
Peru
Prior art keywords
treatment
concentration
prevention
peroxide concentration
peroxide
Prior art date
Application number
PE2002001057A
Other languages
English (en)
Inventor
William J Bologna
Howard L Levine
Original Assignee
Columbia Lab Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Lab Bermuda Ltd filed Critical Columbia Lab Bermuda Ltd
Publication of PE20030492A1 publication Critical patent/PE20030492A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA DE LIBERACION PROLONGADA QUE COMPRENDE UNA MEZCLA SINERGICA DE UNA FUENTE DE PEROXIDO EN UNA CANTIDAD DE 0,01mg A 500mg SELECCIONADO DE PEROXIDO DE CARBAMIDA Y UN BIOADHESIVO TAL COMO UN POLIMERO POLICARBOXILICO, QUE SE HINCHA EN EL AGUA Y QUE ES SOLUBLE EN LA MISMA SELECCIONADO DE POLICARBOFILO, CARACTERIZADA PORQUE SE MANTIENE UNA MUY BAJA CONCENTRACION DE PEROXIDO QUE SE LIBERA DURANTE UN PERIODO PROLONGADO DE AL MENOS 12 HORAS, EN UNA CANTIDAD SUFICIENTE PARA AUMENTAR LA CONCENTRACION DEL OXIGENO EN LA VAGINA, PROPORCIONANDO BENEFICIOS AL DISMINUIR EL pH DE LA VAGINA SIN ESTERILIZACION O SIN ELIMINACION DE LA FLORA VAGINAL LOCAL NORMALMENTE DESEADA. LA COMPOSICION PUEDE SER UTIL PARA EL TRATAMIENTO DE INFECCIONES VAGINALES
PE2002001057A 2001-10-29 2002-10-28 Baja concentracion de peroxido para el tratamiento o prevencion de enfermedades vaginales PE20030492A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33068301P 2001-10-29 2001-10-29
US10/278,910 US7709026B2 (en) 2001-10-29 2002-10-24 Low concentration of peroxide for treating or preventing vaginal infections

Publications (1)

Publication Number Publication Date
PE20030492A1 true PE20030492A1 (es) 2003-06-16

Family

ID=26959335

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002001057A PE20030492A1 (es) 2001-10-29 2002-10-28 Baja concentracion de peroxido para el tratamiento o prevencion de enfermedades vaginales

Country Status (30)

Country Link
US (1) US7709026B2 (es)
EP (1) EP1441769B1 (es)
JP (2) JP5153049B2 (es)
KR (1) KR101009146B1 (es)
CN (1) CN1578676A (es)
AR (1) AR037047A1 (es)
AT (1) ATE297222T1 (es)
AU (1) AU2002346897B2 (es)
BR (1) BR0213584A (es)
CA (1) CA2465133C (es)
DE (1) DE60204584T2 (es)
DK (1) DK1441769T3 (es)
ES (1) ES2243772T3 (es)
HR (1) HRP20040480B1 (es)
HU (1) HU229487B1 (es)
IL (2) IL161512A0 (es)
MA (1) MA26289A1 (es)
ME (1) MEP34608A (es)
MX (1) MXPA04003977A (es)
MY (1) MY137791A (es)
NO (1) NO20042199L (es)
NZ (1) NZ532294A (es)
PE (1) PE20030492A1 (es)
PL (2) PL402550A1 (es)
PT (1) PT1441769E (es)
RS (1) RS51154B (es)
RU (1) RU2329829C2 (es)
SI (1) SI1441769T1 (es)
WO (1) WO2003037382A1 (es)
ZA (1) ZA200402943B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8425892B2 (en) * 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
CH697081A5 (de) * 2002-01-22 2008-04-30 Andreas F Dr Schaub Zusammensetzung für die Unterstützung der Geburt eines menschlichen Föten.
US20040126369A1 (en) * 2002-12-30 2004-07-01 Richard Payne Delivery of peroxide-generating enzymes to the vaginal tract
DE10328942A1 (de) * 2003-06-27 2005-01-27 Lts Lohmann Therapie-Systeme Ag Transmukosale Darreichungsformen mit verminderter Schleimhautirritation
ES2237298B1 (es) * 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
US20050276865A1 (en) * 2004-05-20 2005-12-15 Servet Buyuktimkin Peroxide compounds for the prevention and treatment of sexual dysfunction in humans
DE102004054552A1 (de) * 2004-11-11 2006-05-18 Hcb Happy Child Birth Holding Ag Neue Zusammensetzung zur Erleichterung der Humangeburt
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
US20120074014A1 (en) * 2010-09-27 2012-03-29 Lutran Industries, Inc. Product typically based on salt of peroxymonosulfuric acid and suitable for medicinal usage, and associated product fabrication
US10383894B2 (en) * 2010-03-17 2019-08-20 Lutran Industries, Inc. Human medicinal treatment using salt of peroxymonosulfuric acid
US9895311B2 (en) 2014-09-25 2018-02-20 Pharmiva Ab Foam-forming compositions and methods for delivering an active to a body cavity
US20180280340A1 (en) * 2017-03-30 2018-10-04 Konstantin Zubovskiy Method of treating and preventing infections
PT3628002T (pt) 2017-05-23 2023-05-10 Pharmiva Ab Composições de formação de espuma para entregar um activo a uma cavidade corporal
BR112021007877A2 (pt) * 2018-10-26 2021-08-03 Viramal Limited composição em gel mucoadesiva
US11850303B2 (en) * 2020-10-27 2023-12-26 Uqora, Inc. Gel and a suppository and methods to provide the gel and suppository
AU2024269773A1 (en) * 2023-05-09 2025-12-04 BioNTech SE Intravaginal formulations of gardnerella endolysins
WO2025125456A1 (en) * 2023-12-12 2025-06-19 BioNTech SE Compositions comprising an endolysin and uses thereof
WO2025217642A1 (en) * 2024-04-12 2025-10-16 The General Hospital Corporation System and method of treating vaginal infections and inflammation

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798053A (en) * 1952-09-03 1957-07-02 Goodrich Co B F Carboxylic polymers
NL88710C (es) * 1954-01-25
NL230864A (es) * 1957-08-27
US4127515A (en) * 1974-10-21 1978-11-28 Colgate-Palmolive Company Waxing sponge
US4607101A (en) * 1981-08-27 1986-08-19 Jaye-Boern Laboratories, Inc. Method of treating acne vulgaris with a composition containing carbamide peroxide
JPH0830004B2 (ja) * 1983-11-14 1996-03-27 コロンビア ラボラトリーズ インコーポレイテッド 生物接着性組成物およびそれにより治療する方法
GB8505402D0 (en) * 1985-03-02 1985-04-03 Ciba Geigy Ag Modified phenolic resins
US4657935A (en) * 1985-07-22 1987-04-14 Carlos Teplicki Real acne control (RAC)
US4923677A (en) * 1985-08-07 1990-05-08 Roy T. Witkin Chemical sterilization
US4997625A (en) * 1985-08-07 1991-03-05 Simon Gilbert I Chemical sterilization
US4670256A (en) * 1985-09-23 1987-06-02 V. Valhalla Corp. Vaginal conditioning for sexual activity
US4781923A (en) * 1987-07-20 1988-11-01 Pellico Michael A Antiseptic gels
US5536743A (en) * 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US6017521A (en) * 1989-10-31 2000-01-25 Columbia Laboratories, Inc. Use of polycarboxylic acid polymers to treat vaginal infections
US5376006A (en) * 1990-03-22 1994-12-27 Ultradent Products, Inc. Dental bleaching compositions and methods for bleaching teeth surfaces
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5573765A (en) * 1991-02-19 1996-11-12 Mark S. Reinhard Composition and method for treatment of vaginal yeast infections
US5340836A (en) * 1991-02-19 1994-08-23 Mark S. Reinhard Composition and method for treatment of vaginal yeast infections
IL97930A (en) * 1991-04-23 1996-06-18 Perio Prod Ltd Preparations for whitening two controlled release products that contain a super-oxygen compound
IT1250421B (it) * 1991-05-30 1995-04-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5571533A (en) * 1992-02-07 1996-11-05 Recordati, S.A., Chemical And Pharmaceutical Company Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
US5667817A (en) * 1992-03-20 1997-09-16 Alcide Corporation Method and composition for prevention and treatment of female lower genital tract microbial infections
US5898037A (en) * 1992-11-13 1999-04-27 Marx; Alvin J. Formulations of magnesium compounds for local application and methods of treatment using the same
US5330761A (en) * 1993-01-29 1994-07-19 Edward Mendell Co. Inc. Bioadhesive tablet for non-systemic use products
US6200557B1 (en) * 1993-07-06 2001-03-13 Perry A. Ratcliff Method of treating HIV by a topical composition
US5489435A (en) * 1993-07-06 1996-02-06 Ratcliff; Perry A. Composition for treatment of abnormal conditions of the epithelium of bodily orifices
US5543150A (en) 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof
UA39965C2 (uk) * 1993-12-03 2001-07-16 Лайфор Леборетріз Лтд Вірусоцидний, бактерицидний та руйнуючий сперматозоїди вагінальний засіб і вагінальний супозиторій ( варіанти )
US5667492A (en) * 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
US5741525A (en) * 1995-10-24 1998-04-21 Marshall University Research Corporation Vaginal pharmaceutical hydrogen peroxide composition
ES2164940T3 (es) * 1995-12-27 2002-03-01 Janssen Pharmaceutica Nv Forma de dosificacion solida bioadhesiva.
US5778886A (en) * 1996-02-27 1998-07-14 Shihata; Alfred Vaginal compositions combining a spermicidal agent and a peroxygen compound
US5819742A (en) * 1996-11-06 1998-10-13 Family Health International Vaginal device for preventing conception or the transmission of sexually transmitted diseases, or both
US6093394A (en) * 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
US5843998A (en) * 1997-06-30 1998-12-01 Song; Jin Skin blemish treatment
US6248358B1 (en) 1998-08-25 2001-06-19 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets and methods of making and using the same
DE69819748T2 (de) 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
US6117859A (en) * 1997-11-04 2000-09-12 The Research Foundation Of State University Of New York Method of relieving chronic inflammation by using 5-alkylsulfonylsalicylanilides
CA2335055A1 (en) 1998-06-19 1999-12-23 Jack Fellman Medical device having anti-infective and contraceptive properties
US6277363B1 (en) * 1998-09-21 2001-08-21 Vortech, Inc. Method and composition for treating chlamydia infection
US6159491A (en) * 1999-02-12 2000-12-12 Biovector Technologies, Inc. Prolonged release bioadhesive vaginal gel dosage form
WO2001028515A1 (en) 1999-10-22 2001-04-26 Líf-Hlaup ehf. Bio-Gels Pharmaceuticals Inc. Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion
US6200551B1 (en) * 2000-01-27 2001-03-13 Susan Ann Morgan Treatment for dry mouth employing carbamide peroxide
US6235314B1 (en) * 2000-08-08 2001-05-22 Sarfaraz K. Niazi Analgesic, anti-inflammatory and skeletal muscle relaxant compositions
EP1328507B1 (en) * 2000-10-02 2007-03-14 The Research Foundation Of State University of New York Naphthylsalicylanilides as antimicrobial and antiinflammatory agents
US20030211173A1 (en) 2002-05-08 2003-11-13 Veach Tom C. Lubrication composition
US7517586B2 (en) * 2003-08-06 2009-04-14 Procter & Gamble Company Absorbent structures comprising coated water-swellable material
US20090156672A1 (en) * 2007-12-17 2009-06-18 Northwestern University Substituted Phenyl Aziridine Precursor Analogs as Modulators of Steroid Receptor Activities

Also Published As

Publication number Publication date
AR037047A1 (es) 2004-10-20
PL216746B1 (pl) 2014-05-30
JP2005510505A (ja) 2005-04-21
HK1063290A1 (en) 2004-12-24
IL161512A0 (en) 2004-09-27
EP1441769B1 (en) 2005-06-08
HRP20040480A2 (en) 2004-10-31
MXPA04003977A (es) 2004-07-08
HU229487B1 (en) 2014-01-28
JP2010248232A (ja) 2010-11-04
RU2329829C2 (ru) 2008-07-27
ES2243772T3 (es) 2005-12-01
MEP34608A (en) 2011-02-10
RU2004116312A (ru) 2005-04-10
DK1441769T3 (da) 2005-09-12
IL161512A (en) 2009-07-20
NO20042199L (no) 2004-05-26
ATE297222T1 (de) 2005-06-15
ZA200402943B (en) 2005-03-30
PL369725A1 (en) 2005-05-02
US7709026B2 (en) 2010-05-04
WO2003037382A1 (en) 2003-05-08
MY137791A (en) 2009-03-31
DE60204584D1 (de) 2005-07-14
CN1578676A (zh) 2005-02-09
PL402550A1 (pl) 2013-08-05
US20030091644A1 (en) 2003-05-15
EP1441769A1 (en) 2004-08-04
HRP20040480B1 (hr) 2007-11-30
HUP0401672A2 (hu) 2005-07-28
KR20050056903A (ko) 2005-06-16
HUP0401672A3 (en) 2008-04-28
CA2465133A1 (en) 2003-05-08
CA2465133C (en) 2012-03-06
RS36604A (sr) 2006-12-15
AU2002346897B2 (en) 2008-04-17
NZ532294A (en) 2006-12-22
SI1441769T1 (sl) 2005-12-31
BR0213584A (pt) 2004-08-24
DE60204584T2 (de) 2006-03-16
JP5153049B2 (ja) 2013-02-27
MA26289A1 (fr) 2004-09-01
RS51154B (sr) 2010-10-31
KR101009146B1 (ko) 2011-01-18
PT1441769E (pt) 2005-08-31

Similar Documents

Publication Publication Date Title
PE20030492A1 (es) Baja concentracion de peroxido para el tratamiento o prevencion de enfermedades vaginales
Basrani et al. Update on endodontic irrigating solutions
US5736582A (en) Method and composition for controlled delivery of nascent oxygen from hydrogen peroxide source for skin treatment
US5958984A (en) Method and composition for skin treatment
PE20020102A1 (es) Composicion topica oral que comprende un agente modulador de la respuesta del huesped frente a patogenos periodontales
ATE421248T1 (de) Antiseptische zusammensetzungen und verfahren
ATE319427T1 (de) Zusammensetzungen zur anwendung von entzündungshemmenden, insbesondere antiseptischen und/oder wundheilenden wirkstoffen im oberen atemwegtrakt und/oder ohr
TR200003074T2 (tr) Poloksamerler ve başka mikrobisidler içeren formülasyon.
BR0113751A (pt) Composições cosméticas e farmacêuticas e seus empregos
CO6251259A2 (es) Formulaciones farmaceuticas de estriol en baja dosis
BR0212163A (pt) Composição para tratamento ou prevenção de infecção em plantas
PL373276A1 (en) Trans-epicutaneous administration form for treating restless leg syndrome
JP2005510505A5 (es)
BR9709595A (pt) Uso de agentes complexadores contendo nitrogênio para tratamento de desodorização e tratamento antimicrobiano da pele e de materiais de fibras têxtil
DE69227259D1 (de) Film zur lokalen arzneistoffabgabe für periodontale behandlung
Farstvedt et al. Update on topical wound medications
Dhamija et al. A Review on Agents for Chemo-mechanical Caries Removal
CN101642467B (zh) 长效消毒膏
UA88446C2 (uk) Препарат, що містить аскорбінову кислоту, для лікування та профілактики вагінальних грибкових інфекцій
US20110086108A1 (en) Dissolving powders that can be mixed with water and used as an oral rinse
ES2242439T3 (es) Composicion para el tratamiento de quemaduras.
ES2147796T3 (es) Composicion para el tratamiento o la prevencion del herpes.
ES2194983T3 (es) Uso de lactoferrina para la fabricacion de un agente preventivo para astigmatismo postoperatorio.
CO5580798A2 (es) Composicion de peroxido de liberacion prolongada para infecciones vaginales
KR200391208Y1 (ko) 순은사가 함유된 양말(덧버선)

Legal Events

Date Code Title Description
FC Refusal